Celltrion
068270.KS
#819
Rank
NZ$53.03 B
Marketcap
NZ$232.56
Share price
-0.67%
Change (1 day)
5.61%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): NZ$5.65

According to Celltrion 's latest financial reports the company's current EPS (TTM) is NZ$5.77. In 2025 the company made an earnings per share (EPS) of NZ$5.48 an increase over its 2024 EPS that were of NZ$2.08.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.653.22%
2025NZ$5.48163.66%
2024NZ$2.08-53.73%
2023NZ$4.49-2.08%
2022NZ$4.58-11.72%
2021NZ$5.192.03%
2020NZ$5.0982.8%
2019NZ$2.7818.31%
2018NZ$2.35-36.33%
2017NZ$3.70161.25%
2016NZ$1.412.86%
2015NZ$1.3817.84%
2014NZ$1.175.87%
2013NZ$1.10-70.85%
2012NZ$3.78134.09%
2011NZ$1.6243.59%
2010NZ$1.1374.49%
2009NZ$0.64317.8%
2008NZ$0.15-71.7%
2007NZ$0.55